3uuo

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
m (Protected "3uuo" [edit=sysop:move=sysop])
Line 3: Line 3:
The entry 3uuo is ON HOLD
The entry 3uuo is ON HOLD
-
Authors: Ho, G. D., Yang, S., Smotryski, J., Bercovici, A., Nechuta, T., Smith, E. M., McElroy, W., Tan, Z., Tulshian, D., Mckittrick, B., Greenlee, W. J., Hruza, A., Xiao, L., Rindgen, D., Guzzi, M., Zhang, X., Bleickardt, C., Mullins, D., Hodgson, R.
+
Authors: Ho, G.D., Yang, S., Smotryski, J., Bercovici, A., Nechuta, T., Smith, E.M., McElroy, W., Tan, Z., Tulshian, D., Mckittrick, B., Greenlee, W.J., Hruza, A., Xiao, L., Rindgen, D., Guzzi, M., Zhang, X., Bleickardt, C., Mullins, D., Hodgson, R.
Description: The discovery of potent, selectivity, and orally bioavailable pyrozoloquinolines as PDE10 inhibitors for the treatment of Schizophrenia
Description: The discovery of potent, selectivity, and orally bioavailable pyrozoloquinolines as PDE10 inhibitors for the treatment of Schizophrenia

Revision as of 06:43, 28 December 2011

Unreleased structure

The entry 3uuo is ON HOLD

Authors: Ho, G.D., Yang, S., Smotryski, J., Bercovici, A., Nechuta, T., Smith, E.M., McElroy, W., Tan, Z., Tulshian, D., Mckittrick, B., Greenlee, W.J., Hruza, A., Xiao, L., Rindgen, D., Guzzi, M., Zhang, X., Bleickardt, C., Mullins, D., Hodgson, R.

Description: The discovery of potent, selectivity, and orally bioavailable pyrozoloquinolines as PDE10 inhibitors for the treatment of Schizophrenia

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools